|
Real-time Estimate
Cboe BZX
10:52:04 17/11/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 14.88 USD | +1.26% |
|
-0.07% | +5.77% |
| 09:13pm | Asian Equities Traded in the US as American Depositary Receipts Fall Sharply in Tuesday Trading | MT |
| 17/11 | Gilead signs generic licensing deals for experimental Ebola drug | RE |
| Market Cap | 1,15500Cr 1.23TCr 1.12TCr 1.03TCr 933.04Cr 1.76TCr 1.82TCr 12TCr 4.92TCr 62TCr 4.62TCr 4.52TCr 1,96400Cr | P/E 2027 * |
31.5x | P/E 2028 * | 23.7x |
|---|---|---|---|---|---|
| Enterprise Value | 1,12500Cr 1.2TCr 1.09TCr 1.01TCr 908.61Cr 1.71TCr 1.78TCr 12TCr 4.79TCr 60TCr 4.5TCr 4.4TCr 1,91300Cr | EV / Sales 2027 * |
3.2x | EV / Sales 2028 * | 2.81x |
| Free-Float |
68.54% | Yield 2027 * |
0.54% | Yield 2028 * | 0.6% |
| Markets | Quality | ||
|---|---|---|---|
NYSE
| RDY | Delayed | |
| RDY | Real-time | ||
| RDDA | Real-time | ||
| RDDA | Delayed | ||
| RDDA | Delayed | ||
| RDDA | Real-time |
Last Transcript: Dr. Reddy's Laboratories Limited
| 1 day | +1.26% | ||
| 1 week | -0.07% | ||
| Current month | +4.80% | ||
| 1 month | +13.53% | ||
| 3 months | +22.63% | ||
| 6 months | +9.19% | ||
| Current year | +5.77% |
| 1 week | 14.6 | 14.94 | |
| 1 month | 13.02 | 15.08 | |
| Current year | 11.36 | 15.67 | |
| 1 year | 11.36 | 15.67 | |
| 3 years | 11.36 | 16.89 | |
| 5 years | 9.58 | 16.89 | |
| 10 years | 5.63 | 16.89 |
| Manager | Title | Age | Since |
|---|---|---|---|
Erez Israeli
CEO | Chief Executive Officer | 59 | 01/07/2019 |
| Director of Finance/CFO | - | 01/08/2024 | |
Sanjay Sharma
COO | Chief Operating Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 58 | 13/05/2014 | |
Gunupati Prasad
CHM | Chairman | 65 | 02/04/2013 |
Leo Puri
BRD | Director/Board Member | 65 | 25/10/2018 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +1.26% | -0.07% | - | - | 1.22TCr | ||
| -1.01% | -1.47% | +38.12% | +138.50% | 1,27500Cr | ||
| -0.63% | -0.21% | +40.38% | +87.05% | 68TCr | ||
| -0.38% | -0.40% | +25.09% | +111.66% | 52TCr | ||
| -0.76% | +1.10% | +41.43% | +70.96% | 39TCr | ||
| -0.25% | -3.04% | +54.59% | +41.08% | 36TCr | ||
| -1.83% | -0.89% | +26.00% | +58.48% | 31TCr | ||
| -1.65% | -0.59% | +1.55% | +34.52% | 29TCr | ||
| -0.61% | -1.55% | +34.04% | +72.59% | 25TCr | ||
| +1.55% | -0.69% | +36.75% | +124.91% | 21TCr | ||
| Average | -0.59% | +0.51% | +33.11% | +82.19% | 47TCr | |
| Weighted average by Cap. | -0.89% | +0.76% | +34.94% | +95.53% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 35TCr 374.16Cr 339.92Cr 314.07Cr 283.69Cr 535.38Cr 554.21Cr 3.78TCr 1.5TCr 19TCr 1.4TCr 1.37TCr 60TCr | 39TCr 418.89Cr 380.56Cr 351.62Cr 317.61Cr 599.38Cr 620.46Cr 4.23TCr 1.68TCr 21TCr 1.57TCr 1.54TCr 67TCr |
| Net income | 3.65TCr 39Cr 35Cr 33Cr 29Cr 56Cr 58Cr 392.62Cr 155.57Cr 1.96TCr 145.95Cr 142.86Cr 6.21TCr | 4.93TCr 53Cr 48Cr 44Cr 40Cr 75Cr 78Cr 530.21Cr 210.08Cr 2.65TCr 197.09Cr 192.92Cr 8.38TCr |
| Net Debt | -3.03TCr -32Cr -29Cr -27Cr -24Cr -46Cr -48Cr -325.24Cr -128.87Cr -1.62TCr -120.9Cr -118.34Cr -5.14TCr | -4.95TCr -53Cr -48Cr -44Cr -40Cr -75Cr -78Cr -531.66Cr -210.65Cr -2.65TCr -197.63Cr -193.45Cr -8.41TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 17/26/17 | $14.86 | +1.11% | 5,68,640 |
| 16/26/16 | $14.70 | -0.27% | 12,32,011 |
| 13/26/13 | $14.74 | +0.07% | 37,13,807 |
| 12/26/12 | $14.73 | -0.74% | 16,54,035 |
| 11/26/11 | $14.84 | -0.13% | 21,76,818 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- DRREDDY Stock
- RDY Stock
Select your edition
All financial news and data tailored to specific country editions

















